HPV causes multiple cancers in both men and women; HPV 16 is a cause of vulvar, vaginal and anal cancers in women, as well as anal, penile, and oropharyngeal cancers in men. While cervical cancer incidence is declining, the incidence of anal cancers and HPV related oropharyngeal cancers is rising. In some regions of the world penile cancer incidence is also increasing. This increase in cancer incidence is occurring for cancers for which there is no routine method for screening and early detection, as there is for cervical cancer. In this presentation the epidemiology of HPV infection in men, and HPV vaccine efficacy in men by race/ethnicity and world region will be presented.

Citation Format: Anna R. Giuliano. Global perspective on the prevention of HPV-related cancers in men: From epidemiology to intervention. [abstract]. In: Proceedings of the Fifth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; 2012 Oct 27-30; San Diego, CA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2012;21(10 Suppl):Abstract nr PL05-02.